BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE

Boehringer Ingelheim Animal Health France specializes in the manufacturing of biological veterinary products, with a demonstrated focus on foot-and-mouth disease vaccines for large-scale animal health programs. The contractor leverages advanced biomanufacturing processes to produce high-volume, standardized biological therapeutics, including inactivated viral vaccines, tailored for use in livestock populations. Their technical expertise lies in antigen formulation, cold-chain logistics for biologicals, and compliance with international veterinary biologics standards, ensuring product stability and efficacy under operational field conditions. A key differentiator is their capacity to deliver consistent, large-dose batches of veterinary vaccines to support national animal disease control initiatives, particularly those targeting transboundary livestock pathogens. The contractor maintains a consistent relationship with the U.S. Department of Agriculture, providing critical veterinary biologicals to support federal animal health defense and emergency response programs. Work performed centers on the procurement and delivery of foot-and-mouth disease vaccines for use in national surveillance and outbreak preparedness efforts, often coordinated through specialized veterinary service units. This recurring engagement reflects a trusted, mission-critical supplier relationship built on reliability, regulatory adherence, and timely production scaling. Their primary industry focus is biological product manufacturing under NAICS 325414, which encompasses the production of non-diagnostic biologicals for animal use. This places them squarely within the veterinary biologics sector, serving government-led animal health security and agricultural protection markets. They are positioned as a specialized producer of high-compliance, large-scale veterinary vaccines rather than a broad-spectrum animal health company. Boehringer Ingelheim Animal Health France operates as a foreign subsidiary with no known U.S. government certifications. The entity is based in Lyon, France, and serves the U.S. government market exclusively through export-driven contracts, functioning as an international supplier of critical veterinary biologics to federal agencies engaged in animal disease mitigation.